 Home > Biochemistry News > Biotechnology News > Gilead Trodelvy receives positive opinion from EU CHMP for treatment of breast cancer

Gilead Trodelvy receives positive opinion from EU CHMP for treatment of breast cancer

 Last Update: 2021-11-16
 Source: Internet
 Author: User

Tags

kill cancer

food drug administration act

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

CompilationFan Dongdong

A few days ago, Gilead ADC drug Trodelvy has received positive opinions from the European Medicines Agency (EMA) Committee on Medicinal Products for Human Use (CHMP) for monotherapy in adult patients with unresectable or metastatic triple-negative breast cancer (TNBC)

This time Trodelvy received positive opinions from the European Union, mainly based on the positive results of the Phase 3 ASCENT trial

Just 5 months ago, the FDA approved Gilead Trodelvy for the same indication in April, and the drug is currently on the market in the UK, Australia, Switzerland and Canada

Trodelvy was originally developed by Immunomedics.

Trodelvy is a new and pioneering antibody-conjugated drug (ADC) targeting Trop-2.

In addition, Gilead’s development plan for Trodelvy also includes the exploration of multiple other solid tumor indications, such as other types of metastatic triple-negative breast cancer and metastatic urothelial cancer, hormone receptor positive/human epidermal growth 2- negative factor receptor (HR + / HER2-) metastatic breast cancer and metastatic non-small cell lung cancer

In terms of competitors, in March 2019, the U.

Reference source: Gilead's Trodelvy set for EU approval in breast cancer

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.